Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Cannabidiol
Therapeutic Area : Neurology
Study Phase : Preclinical
Sponsor : Verdepharmhealth
Deal Size : Undisclosed
Deal Type : Partnership
Details : Collaboration will utilize proprietary CBD-Cubed™ transdermal 24-hour delivery technology for multi-specialty patients.
Product Name : Undisclosed
Product Type : Controlled Substance
Upfront Cash : Undisclosed
October 06, 2020
Lead Product(s) : Cannabidiol
Therapeutic Area : Neurology
Highest Development Status : Preclinical
Sponsor : Verdepharmhealth
Deal Size : Undisclosed
Deal Type : Partnership